table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2030)
1.4.2 East Asia Market States and Outlook (2023-2030)
1.4.3 Europe Market States and Outlook (2023-2030)
1.4.4 South Asia Market States and Outlook (2023-2030)
1.4.5 Southeast Asia Market States and Outlook (2023-2030)
1.4.6 Middle East Market States and Outlook (2023-2030)
1.4.7 Africa Market States and Outlook (2023-2030)
1.4.8 Oceania Market States and Outlook (2023-2030)
1.4.9 South America Market States and Outlook (2023-2030)
1.5 Global NASH Therapeutic Drugs Market Size Analysis from 2023 to 2030
1.5.1 Global NASH Therapeutic Drugs Market Size Analysis from 2023 to 2030 by Consumption Volume
1.5.2 Global NASH Therapeutic Drugs Market Size Analysis from 2023 to 2030 by Value
1.5.3 Global NASH Therapeutic Drugs Price Trends Analysis from 2023 to 2030
1.6 COVID-19 Outbreak: NASH Therapeutic Drugs Industry Impact
Chapter 2 Global NASH Therapeutic Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global NASH Therapeutic Drugs (Volume and Value) by Type
2.1.1 Global NASH Therapeutic Drugs Consumption and Market Share by Type (2017-2022)
2.1.2 Global NASH Therapeutic Drugs Revenue and Market Share by Type (2017-2022)
2.2 Global NASH Therapeutic Drugs (Volume and Value) by Application
2.2.1 Global NASH Therapeutic Drugs Consumption and Market Share by Application (2017-2022)
2.2.2 Global NASH Therapeutic Drugs Revenue and Market Share by Application (2017-2022)
2.3 Global NASH Therapeutic Drugs (Volume and Value) by Regions
2.3.1 Global NASH Therapeutic Drugs Consumption and Market Share by Regions (2017-2022)
2.3.2 Global NASH Therapeutic Drugs Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global NASH Therapeutic Drugs Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global NASH Therapeutic Drugs Consumption by Regions (2017-2022)
4.2 North America NASH Therapeutic Drugs Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia NASH Therapeutic Drugs Sales, Consumption, Export, Import (2017-2022)
4.4 Europe NASH Therapeutic Drugs Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia NASH Therapeutic Drugs Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia NASH Therapeutic Drugs Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East NASH Therapeutic Drugs Sales, Consumption, Export, Import (2017-2022)
4.8 Africa NASH Therapeutic Drugs Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania NASH Therapeutic Drugs Sales, Consumption, Export, Import (2017-2022)
4.10 South America NASH Therapeutic Drugs Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America NASH Therapeutic Drugs Market Analysis
5.1 North America NASH Therapeutic Drugs Consumption and Value Analysis
5.1.1 North America NASH Therapeutic Drugs Market Under COVID-19
5.2 North America NASH Therapeutic Drugs Consumption Volume by Types
5.3 North America NASH Therapeutic Drugs Consumption Structure by Application
5.4 North America NASH Therapeutic Drugs Consumption by Top Countries
5.4.1 United States NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
5.4.2 Canada NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
5.4.3 Mexico NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
Chapter 6 East Asia NASH Therapeutic Drugs Market Analysis
6.1 East Asia NASH Therapeutic Drugs Consumption and Value Analysis
6.1.1 East Asia NASH Therapeutic Drugs Market Under COVID-19
6.2 East Asia NASH Therapeutic Drugs Consumption Volume by Types
6.3 East Asia NASH Therapeutic Drugs Consumption Structure by Application
6.4 East Asia NASH Therapeutic Drugs Consumption by Top Countries
6.4.1 China NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
6.4.2 Japan NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
6.4.3 South Korea NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
Chapter 7 Europe NASH Therapeutic Drugs Market Analysis
7.1 Europe NASH Therapeutic Drugs Consumption and Value Analysis
7.1.1 Europe NASH Therapeutic Drugs Market Under COVID-19
7.2 Europe NASH Therapeutic Drugs Consumption Volume by Types
7.3 Europe NASH Therapeutic Drugs Consumption Structure by Application
7.4 Europe NASH Therapeutic Drugs Consumption by Top Countries
7.4.1 Germany NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
7.4.2 UK NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
7.4.3 France NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
7.4.4 Italy NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
7.4.5 Russia NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
7.4.6 Spain NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
7.4.7 Netherlands NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
7.4.8 Switzerland NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
7.4.9 Poland NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
Chapter 8 South Asia NASH Therapeutic Drugs Market Analysis
8.1 South Asia NASH Therapeutic Drugs Consumption and Value Analysis
8.1.1 South Asia NASH Therapeutic Drugs Market Under COVID-19
8.2 South Asia NASH Therapeutic Drugs Consumption Volume by Types
8.3 South Asia NASH Therapeutic Drugs Consumption Structure by Application
8.4 South Asia NASH Therapeutic Drugs Consumption by Top Countries
8.4.1 India NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
8.4.2 Pakistan NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
8.4.3 Bangladesh NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia NASH Therapeutic Drugs Market Analysis
9.1 Southeast Asia NASH Therapeutic Drugs Consumption and Value Analysis
9.1.1 Southeast Asia NASH Therapeutic Drugs Market Under COVID-19
9.2 Southeast Asia NASH Therapeutic Drugs Consumption Volume by Types
9.3 Southeast Asia NASH Therapeutic Drugs Consumption Structure by Application
9.4 Southeast Asia NASH Therapeutic Drugs Consumption by Top Countries
9.4.1 Indonesia NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
9.4.2 Thailand NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
9.4.3 Singapore NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
9.4.4 Malaysia NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
9.4.5 Philippines NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
9.4.6 Vietnam NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
9.4.7 Myanmar NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
Chapter 10 Middle East NASH Therapeutic Drugs Market Analysis
10.1 Middle East NASH Therapeutic Drugs Consumption and Value Analysis
10.1.1 Middle East NASH Therapeutic Drugs Market Under COVID-19
10.2 Middle East NASH Therapeutic Drugs Consumption Volume by Types
10.3 Middle East NASH Therapeutic Drugs Consumption Structure by Application
10.4 Middle East NASH Therapeutic Drugs Consumption by Top Countries
10.4.1 Turkey NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
10.4.3 Iran NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
10.4.5 Israel NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
10.4.6 Iraq NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
10.4.7 Qatar NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
10.4.8 Kuwait NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
10.4.9 Oman NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
Chapter 11 Africa NASH Therapeutic Drugs Market Analysis
11.1 Africa NASH Therapeutic Drugs Consumption and Value Analysis
11.1.1 Africa NASH Therapeutic Drugs Market Under COVID-19
11.2 Africa NASH Therapeutic Drugs Consumption Volume by Types
11.3 Africa NASH Therapeutic Drugs Consumption Structure by Application
11.4 Africa NASH Therapeutic Drugs Consumption by Top Countries
11.4.1 Nigeria NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
11.4.2 South Africa NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
11.4.3 Egypt NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
11.4.4 Algeria NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
11.4.5 Morocco NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
Chapter 12 Oceania NASH Therapeutic Drugs Market Analysis
12.1 Oceania NASH Therapeutic Drugs Consumption and Value Analysis
12.2 Oceania NASH Therapeutic Drugs Consumption Volume by Types
12.3 Oceania NASH Therapeutic Drugs Consumption Structure by Application
12.4 Oceania NASH Therapeutic Drugs Consumption by Top Countries
12.4.1 Australia NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
12.4.2 New Zealand NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
Chapter 13 South America NASH Therapeutic Drugs Market Analysis
13.1 South America NASH Therapeutic Drugs Consumption and Value Analysis
13.1.1 South America NASH Therapeutic Drugs Market Under COVID-19
13.2 South America NASH Therapeutic Drugs Consumption Volume by Types
13.3 South America NASH Therapeutic Drugs Consumption Structure by Application
13.4 South America NASH Therapeutic Drugs Consumption Volume by Major Countries
13.4.1 Brazil NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
13.4.2 Argentina NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
13.4.3 Columbia NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
13.4.4 Chile NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
13.4.5 Venezuela NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
13.4.6 Peru NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
13.4.8 Ecuador NASH Therapeutic Drugs Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in NASH Therapeutic Drugs Business
14.1 Allergan Plc (Tobira)
14.1.1 Allergan Plc (Tobira) Company Profile
14.1.2 Allergan Plc (Tobira) NASH Therapeutic Drugs Product Specification
14.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Genfit SA
14.2.1 Genfit SA Company Profile
14.2.2 Genfit SA NASH Therapeutic Drugs Product Specification
14.2.3 Genfit SA NASH Therapeutic Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Bristol Myers Squibb
14.3.1 Bristol Myers Squibb Company Profile
14.3.2 Bristol Myers Squibb NASH Therapeutic Drugs Product Specification
14.3.3 Bristol Myers Squibb NASH Therapeutic Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Zydus Cadila
14.4.1 Zydus Cadila Company Profile
14.4.2 Zydus Cadila NASH Therapeutic Drugs Product Specification
14.4.3 Zydus Cadila NASH Therapeutic Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Galmed Pharmaceuticals
14.5.1 Galmed Pharmaceuticals Company Profile
14.5.2 Galmed Pharmaceuticals NASH Therapeutic Drugs Product Specification
14.5.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Intercept Pharmaceuticals, Inc.
14.6.1 Intercept Pharmaceuticals, Inc. Company Profile
14.6.2 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product Specification
14.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Gilead Sciences, Inc.
14.7.1 Gilead Sciences, Inc. Company Profile
14.7.2 Gilead Sciences, Inc. NASH Therapeutic Drugs Product Specification
14.7.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global NASH Therapeutic Drugs Market Forecast (2023-2030)
15.1 Global NASH Therapeutic Drugs Consumption Volume, Revenue and Price Forecast (2023-2030)
15.1.1 Global NASH Therapeutic Drugs Consumption Volume and Growth Rate Forecast (2023-2030)
15.1.2 Global NASH Therapeutic Drugs Value and Growth Rate Forecast (2023-2030)
15.2 Global NASH Therapeutic Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2023-2030)
15.2.1 Global NASH Therapeutic Drugs Consumption Volume and Growth Rate Forecast by Regions (2023-2030)
15.2.2 Global NASH Therapeutic Drugs Value and Growth Rate Forecast by Regions (2023-2030)
15.2.3 North America NASH Therapeutic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.4 East Asia NASH Therapeutic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.5 Europe NASH Therapeutic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.6 South Asia NASH Therapeutic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.7 Southeast Asia NASH Therapeutic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.8 Middle East NASH Therapeutic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.9 Africa NASH Therapeutic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.10 Oceania NASH Therapeutic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.11 South America NASH Therapeutic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.3 Global NASH Therapeutic Drugs Consumption Volume, Revenue and Price Forecast by Type (2023-2030)
15.3.1 Global NASH Therapeutic Drugs Consumption Forecast by Type (2023-2030)
15.3.2 Global NASH Therapeutic Drugs Revenue Forecast by Type (2023-2030)
15.3.3 Global NASH Therapeutic Drugs Price Forecast by Type (2023-2030)
15.4 Global NASH Therapeutic Drugs Consumption Volume Forecast by Application (2023-2030)
15.5 NASH Therapeutic Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
